Related Experiment Video

Updated: Apr 7, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.6K

Targeting MYC Translation in Colorectal Cancer

Alina Castell1, Lars-Gunnar Larsson2

  • 1Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.

Cancer Discovery
|July 9, 2015
PubMed

Insights

Researchers found a new way to inhibit MYC, a deadly cancer oncoprotein. Targeting the translation factor eIF4A stops MYC production, hindering colorectal tumor cell growth in lab and animal studies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • MYC is a critical transcription regulator and a major oncoprotein driving human cancer.
  • Targeting MYC has been challenging due to its "undruggable" status.
  • Effective strategies to inhibit MYC expression or activity are urgently needed.

Purpose of the Study:

  • To investigate a novel method for inhibiting MYC in colorectal cancer.
  • To explore the potential of targeting translation initiation factors for MYC inhibition.

Main Methods:

  • Directly targeting the translation initiation factor eIF4A.
  • Assessing the inhibition of MYC translation in colorectal cancer cells.
  • Evaluating the impact on MYC-dependent proliferation in vitro and in vivo.

Main Results:

  • Successful inhibition of MYC translation by targeting eIF4A.
  • Demonstrated reduction in MYC-dependent proliferation of colorectal tumor cells.
  • Validation of the therapeutic approach in both cell culture and animal models.

Conclusions:

  • Targeting eIF4A offers a promising strategy to inhibit MYC translation.
  • This approach effectively suppresses colorectal tumor cell proliferation.
  • The findings provide a new avenue for developing therapies against MYC-driven cancers.

More Related Videos

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer06:19

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

Published on: July 18, 2017

10.9K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

6.1K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K